Abstract
Nanotechnology involves manipulating matter at the scale of atoms and molecules. More specifically it deals with materials and devices with sizes in the range of 1–100 nanometers (nm, 1 nanometer = 1 × 10−9 m), as well as processes operating at that level.) Many molecules within the human body fall within that range of sizes. For example, proteins have dimensions between 1 to 20 nm, the width of a DNA helix is about 2.5 nm, and even ribosomes, the protein-constructing organelles within cells, have diameters of about 2–4 nm. Indeed, our bodies are living models of “natural” nanotechnology in action.
To see a world in a grain of sand…
William Blake
“Auguries of Innocence”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The novelization of this film was created by an author with some prior experience writing science fiction, one “Isaac Asimov.”
- 2.
Although they look nothing like the one shown in the movie, modern medicine does sometimes employ lasers as part of a catheter system to help destroy plaque and blood clots in blocked arteries. Effective “thrombolytic” medications are also available for this purpose. Unfortunately miniaturized submarines are not yet part of standard medical practice.
- 3.
Analog Science Fiction and Fact July/August 2012.
- 4.
However, unlike the Borg I was not practicing medicine without a license when I did it.
- 5.
Drexler has given an updated assessment of the potentials of nanotechnology in a more recent book, Radical Abundance. How a Revolution in Nanotechnology Will Change Civilization (2013).
- 6.
This capability would make them, at least in one sense of the term, what have been called “von Neumann machines.”
- 7.
Another “health benefit” of gold nanoparticles might also be as an effective defense against attacks by Cybermen, as suggested by the Doctor Who serials “Revenge of the Cybermen” (1975) and “Earthshock” (1982).
- 8.
See Chap. 12 for more details about gene therapy.
- 9.
Chapter 14 will describe the current status of such interfaces.
References
Ranganathan R, Madanmohan S, Kesavan A, Baskar G, Krishnamoorthy YR, Santosham R, et al. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. Int J Nanomed. 2012;7:1043–60.
Kim B, Rutka J, Chan WC. Nanomedicine. N Engl J Med. 2010;363(25):2434–43.
Wong KK, Liu XL. Nanomedicine: a primer for surgeons. Pediatr Surg Int. 2012;28(10):943–51.
Feynman R. There’s plenty of room at the bottom. Eng Sci. 1960;23:22–36.
Drexler KE. Molecular engineering: an approach to the development of general capabilities for molecular manipulation. Proc Natl Acad Sci. 1981;78(9):5275–8.
Drexler KE. Engines of creation. The coming era of nanotechnology. New York: Anchor Books; 1986.
Drexler KE. Nanosystems. Molecular machinery, manufacturing, and computation. New York: Wiley; 1992.
Hall JS. Nanofuture. What’s next for nanotechnology. Amherst: Prometheus Books; 2005.
Jain K. The handbook of nanomedicine. New York: Humana Press; 2008.
Kleinsmith L, Kish V. Energy and enzymes. Principles of cell and molecular biology, (Chapter 2). New York: HarperCollins; 1995.
Nanotechnology. Research and perspectives. Cambridge: The MIT Press; 1992.
Prospects in Nanotechnology. Toward Molecular Manufacturing. New York: Wiley; 1995.
Freitas R. Nanomedicine. Basic capabilities. Austin: Landes Bioscience; 1999.
Leduc P, Wong M, Ferreira P, Groff R, Haslinger K, Koonce M, et al. Towards an in vivo biologically inspired nanofactory. Nat Nanotechnol. 2007;2(January):3–7.
Chou LY, Zagorovsky K, Chan WC. DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat Nanotechnol. 2014;9(2):148–55.
Toumey C. Nanobots today. Nat Nanotechnol. 2013;8(7):475–6.
McCall MJ. Environmental, health and safety issues: nanoparticles in the real world. Nat Nanotechnol. 2011;6(10):613–4.
Soppimath K, Betageri G. Nanostructures for cancer diagnostics and therapy. In: Gonsalves K, Halberstadt C, Laurencin C, Nair L, editors. Biomedical nanostructures. Hoboken: Wiley; 2008. pp. 409–37.
Labouta HI, Schneider M. Interaction of inorganic nanoparticles with the skin barrier: current status and critical review. Nanomedicine. 2013;9(1):39–54.
Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012;14(2):282–95.
Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Rev Mol Diagn. 2013;13(3):257–69.
Yu X, Valmikinathan C, Rogers A, Wang J. Nanotechnology and drug delivery. In: Gonsalves K, Halberstadt C, Laurencin C, Nair L, editors. Biomedical nanostructures. Hoboken: Wiley; 2008. pp. 93–113.
Guan J, He H, Yu B, Lee L. Polymeric nanoparticles and nanopore membranes for controlled drug and gene delivery.In: Gonsalves K, Halberstadt C, Laurencin C, Nair L, editors. Biomedical nanostructures. Hoboken: Wiley; 2008. pp. 115–37.
Wang LS, Chuang MC, Ho JA. Nanotheranostics–a review of recent publications. Int J Nanomedicine. 2012;7:4679–95.
Tong R, Kohane D. Shedding light on nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(6):638–62.
Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol. 2009;4(10):669–73.
Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev. 2012;64(13):1363–84.
Madani SY, Shabani F, Dwek MV, Seifalian AM. Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine. 2013;8:941–50.
Thakor A, Gambhir S. Nanooncology: The future of cancer diagnosis and therapy. CA Cancer J Clin. 2013;63:395–418.
Waite C, Roth C. Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: Current progress and opportunities. Crit Rev Biomed Eng. 2012;40(1):21–41.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo S, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Research Letters. 2013;8(102):1–9.
Miller SM, Wang AZ. Nanomedicine in chemoradiation. Ther Deliv. 2013;4(2):239–50.
Novoselov KS, Fal’ko VI, Colombo L, Gellert PR, Schwab MG, Kim K. A roadmap for graphene. Nature. 2012;490(7419):192–200.
Peplow M. The quest for supercarbon. Nature. 2013;503:327–9.
Mulvey JJ, Villa CH, McDevitt MR, Escorcia FE, Casey E, Scheinberg DA. Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery. Nat Nanotechnol. 2013;8(10):763–71.
Liu Y, Wang H. Nanotechnology tackles tumours. Nat Nanotechnol. 2007;2(January):20–1.
Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol. 2009;4(10):627–33.
Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano. 2009;3(11):3707–13.
Grebowski J, Kazmierska P, Krokosz A. Fullerenols as a new therapeutic approach in nanomedicine. Biomed Res Int. 2013;2013:751913.
Da Silva A, Santos R, Xisto D, Alonso S, Morales M, Rocco P. Nanoparticle-based therapy for respiratory diseases. Ann Braz Acad Sci. 2013;85:137–46.
Parboosing R, Maguire GE, Govender P, Kruger HG. Nanotechnology and the treatment of HIV infection. Viruses. 2012;4(4):488–520.
Johnson D. Nanomotors could churn inside of cancer cells to mush. 2014. http://spectrum.ieee.org/nanoclast/biomedical/devices/nanomotors-could-churn-inside-of-cancer-cells-to-mush. Accessed 15 April 2015.
Wang W, Li S, Mair L, Ahmed S, Huang TJ, Mallouk TE. Acoustic propulsion of nanorod motors inside living cells. Angew Chem Int Ed. 2014;53:3201-4.
Silva G. Shorting neurons with nanotubes. Nat Nanotechnol. 2009;4(February):82–3.
Hartgerink J. New material stops bleeding in a hurry. Nat Nanotechnol. 2006;1(December):166–7.
Koria P, Yagi H, Kitagawa Y, Megeed Z, Nahmias Y, Sheridan R, et al. Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc Natl Acad Sci U S A. 2011;108(3):1034–9.
Ruan L, Zhang H, Luo H, Liu J, Tang F, Shi YK, et al. Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis. Proc Natl Acad Sci U S A. 2009;106(13):5105–10.
Higgins P, Dawson J, Walters M. Nanomedicine: nanotubes reduce stroke damage. Nat Nanotechnol. 2011;6(2):83–4.
Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol. 2011;6(11):720–5.
Dvir T, Timko BP, Kohane DS, Langer R. Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol. 2011;6(1):13–22.
Jaconi ME. Nanomedicine: gold nanowires to mend a heart. Nat Nanotechnol. 2011;6(11):692–3.
Hosseinkhani H, He W-J, Chiang C-H, Hong P-D, Yu D-S, Domb AJ, et al. Biodegradable nanoparticles for gene therapy technology. J Nanopart Res. 2013;15(7):1794.
Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, Koido S, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol. 2009;4(9):598–606.
Plank C. Nanomedicine: silence the target. Nat Nanotechnol. 2009;4(9):544–5.
Morrison D, Dokmeci M, Demirci U, Khademhosseini A. Clinical applications of micro- and nanoscale biosensors. In: Gonsalves K, Halberstadt C, Laurencin C, Nair L, editors. Biomedical nanostructures. Wiley; 2008:439–60.
Dawson K, Salvati A, Lynch I. Nanoparticles reconstruct lipids. Nat Nanotechnol. 2009;4(February):84–5.
Kleinsmith L, Kish V. Chapter 1. Prologue: cells and their molecules. Principles of cell and molecular biology, 2nd edn. New York: HarperCollins; 1995.
DNA Microarray Technology. 2011. http://www.genome.gov/pfv.cfm?pageID=10000533. Accessed 15 April 2015.
Hashimoto M, Tong R, Kohane DS. Microdevices for nanomedicine. Mol Pharm. 2013;10(6):2127–44.
Behra R, Krug H. Nanoparticles at large. Nat Nanotechnol. 2008;3(May):253–4.
Lee Y, Cho M. Application of nanotechnology into life science: benefit or risk. In: Gonsalves K, Halberstadt C, Laurencin C, Nair L, editors. Biomedical nanostructures. Hoboken: Wiley; 2008. pp. 491–501.
Minchin R. Sizing up targets with nanoparticles. Nat Nanotechnol. 2008;3(January):12–3.
Zhao Y, Xing G, Chai Z. Are carbon nanotubes safe? Nat Nanotechnol. 2008;3(April):191–2.
Elder A. How do nanotubes suppress T cells? Nat Nanotechnol. 2009;4(July):409–10.
Kanwar JR, Sriramoju B, Kanwar RK. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier. Int J Nanomedicine. 2012;7:3259–78.
Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol. 2009;4(7):411–4.
Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol. 2009;4(12):876–83.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Stratmann, H. (2016). The Promises and Perils of Medical Nanotechnology. In: Using Medicine in Science Fiction. Science and Fiction. Springer, Cham. https://doi.org/10.1007/978-3-319-16015-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-16015-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16014-6
Online ISBN: 978-3-319-16015-3
eBook Packages: MedicineMedicine (R0)